Alexander W. Wyatt
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 75
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 96
- Prostate Cancer Diagnosis and Treatment 24
- Renal cell carcinoma treatment 12
- Oncology top 2%
- PARP inhibition in cancer therapy 14
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 12
-
- Radiopharmaceutical Chemistry and Applications 20
-
- Bladder and Urothelial Cancer Treatments 23
- Co-authors
- Martin GleaveKim N.Matti AnnalaColin C. CollinsKevin BejaMatti NykterArun AzadGillian Vandekerkhove
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (36 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Alexander W. Wyatt
141 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 2.3k
- Pulmonary and Respiratory Medicine 3.3k
- Oncology 1.4k
- Molecular Biology 2.0k
- Radiology, Nuclear Medicine and Imaging 567
Countries citing papers authored by Alexander W. Wyatt
This map shows the geographic impact of Alexander W. Wyatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander W. Wyatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander W. Wyatt more than expected).
Fields of papers citing papers by Alexander W. Wyatt
This network shows the impact of papers produced by Alexander W. Wyatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander W. Wyatt. The network helps show where Alexander W. Wyatt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexander W. Wyatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 26 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 52 | |
| 9 | 2021 | 52 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 109 | |
| 12 | 2020 | 12 | |
| 13 | Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancerbreakdown → | 2018 | 347 |
| 14 | 2018 | 8 | |
| 15 | 2017 | 52 | |
| 16 | 2016 | 75 | |
| 17 | 2016 | 263 | |
| 18 | 2016 | 53 | |
| 19 | Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancerbreakdown → | 2015 | 367 |
| 20 | 2015 | 105 |
About Alexander W. Wyatt
Alexander W. Wyatt is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 157 papers that have together received 5.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (96 papers), Cancer Genomics and Diagnostics (75 papers), Prostate Cancer Diagnosis and Treatment (24 papers), Bladder and Urothelial Cancer Treatments (23 papers), Radiopharmaceutical Chemistry and Applications (20 papers), PARP inhibition in cancer therapy (14 papers), Renal cell carcinoma treatment (12 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Cancer Research (2.3k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Oncology (1.4k citations). Alexander W. Wyatt has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Martin Gleave, Kim N., Matti Annala, Colin C. Collins, Kevin Beja, Matti Nykter, Arun Azad, Gillian Vandekerkhove, Evan W. Warner and Stanislav Volik. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.